These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29044290)

  • 1. Protease-Activated Receptor PAR-4: An Inducible Switch between Thrombosis and Vascular Inflammation?
    Fender AC; Rauch BH; Geisler T; Schrör K
    Thromb Haemost; 2017 Nov; 117(11):2013-2025. PubMed ID: 29044290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
    Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
    Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
    Lee H; Sturgeon SA; Jackson SP; Hamilton JR
    Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of protease-activated receptor-1 antagonists.
    Derian CK; Maryanoff BE; Zhang HC; Andrade-Gordon P
    Expert Opin Investig Drugs; 2003 Feb; 12(2):209-21. PubMed ID: 12556215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition.
    Meah MN; Raftis J; Wilson SJ; Perera V; Garonzik SM; Murthy B; Everlof JG; Aronson R; Luettgen J; Newby DE
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2678-2685. PubMed ID: 32907366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis.
    Iba T; Levy JH
    J Thromb Haemost; 2018 Feb; 16(2):231-241. PubMed ID: 29193703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific activation, signalling and secretion profiles of human platelets following PAR-1 and PAR-4 stimulation.
    Nguyen KA; Hamzeh-Cognasse H; Laradi S; Pozzetto B; Garraud O; Cognasse F
    Platelets; 2015; 26(8):795-8. PubMed ID: 26083907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin receptors in vascular smooth muscle cells - function and regulation by vasodilatory prostaglandins.
    Schrör K; Bretschneider E; Fischer K; Fischer JW; Pape R; Rauch BH; Rosenkranz AC; Weber AA
    Thromb Haemost; 2010 May; 103(5):884-90. PubMed ID: 20143010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-protein coupled receptor antagonists-1: protease activated receptor-1 (PAR-1) antagonists as novel cardiovascular therapeutic agents.
    Chackalamannil S
    Curr Top Med Chem; 2003; 3(10):1115-23. PubMed ID: 12769712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand.
    Moschonas IC; Kellici TF; Mavromoustakos T; Stathopoulos P; Tsikaris V; Magafa V; Tzakos AG; Tselepis AD
    Platelets; 2017 Dec; 28(8):812-821. PubMed ID: 28267389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine-1-phosphate induces thrombin receptor PAR-4 expression to enhance cell migration and COX-2 formation in human monocytes.
    Mahajan-Thakur S; Sostmann BD; Fender AC; Behrendt D; Felix SB; Schrör K; Rauch BH
    J Leukoc Biol; 2014 Oct; 96(4):611-8. PubMed ID: 24990321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
    Gudmundsdóttir IJ; Lang NN; Boon NA; Ludlam CA; Webb DJ; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 May; 51(18):1749-56. PubMed ID: 18452780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.
    Duvernay MT; Temple KJ; Maeng JG; Blobaum AL; Stauffer SR; Lindsley CW; Hamm HE
    Mol Pharmacol; 2017 Jan; 91(1):39-47. PubMed ID: 27784794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of CLEC-2 and Its Ligands in Thromboinflammation.
    Meng D; Luo M; Liu B
    Front Immunol; 2021; 12():688643. PubMed ID: 34177942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
    Etulain J; Mena HA; Negrotto S; Schattner M
    Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.
    Derian CK; Damiano BP; Addo MF; Darrow AL; D'Andrea MR; Nedelman M; Zhang HC; Maryanoff BE; Andrade-Gordon P
    J Pharmacol Exp Ther; 2003 Feb; 304(2):855-61. PubMed ID: 12538843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.
    Karpman D; Ståhl AL; Arvidsson I; Johansson K; Loos S; Tati R; Békássy Z; Kristoffersson AC; Mossberg M; Kahn R
    Adv Exp Med Biol; 2015; 865():19-42. PubMed ID: 26306441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using PAR4 Inhibition as an Anti-Thrombotic Approach: Why, How, and When?
    Li S; Tarlac V; Hamilton JR
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptors in the cardiovascular system.
    Coughlin SR
    Cold Spring Harb Symp Quant Biol; 2002; 67():197-208. PubMed ID: 12858541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.